Dyne Therapeutics (DYN) Other Operating Expenses (2021 - 2026)
Dyne Therapeutics' (DYN) quarterly Other Operating Expenses came in at -$133000.0 in Q1 2026, down 49.44% year-on-year from -$263044.4 in Q1 2025, and up 53.98% on a QoQ basis from -$289000.0 in Q4 2025.
Dyne Therapeutics (DYN) Other Operating Expenses (2021 - 2026) Analysis & Trends
Dyne Therapeutics (DYN) has 6 years of Other Operating Expenses data on file, last reported at -$133000.0 in Q1 2026.
- On a quarterly basis, Other Operating Expenses fell 49.44% year-over-year to -$133000.0 in Q1 2026; TTM through Mar 2026 was -$1.7 million, a 65.87% decrease from a year earlier, with the FY2025 full-year figure at -$1.7 million, down 273.79% from the prior year.
- Other Operating Expenses for Q1 2026 stood at -$133000.0, up from -$289000.0 in the prior quarter.
- Over the last five years, Other Operating Expenses for DYN reached as high as $506000.0 in Q1 2024 and fell as low as -$1.6 million in Q2 2025.
- Historically, Other Operating Expenses has averaged -$220705.9 across 5 years, with a median of -$126000.0 in 2023.
- Across the five-year window, Other Operating Expenses slumped 3830.0% in 2023 and soared 334.26% in 2024, its largest moves.
- Year by year, Other Operating Expenses stood at -$24000.0 in 2022, then tumbled by 2820.83% to -$701000.0 in 2023, then jumped by 96.29% to -$26000.0 in 2024, then sank by 1011.54% to -$289000.0 in 2025, then jumped by 53.98% to -$133000.0 in 2026.
- Per Business Quant data, the three most recent Other Operating Expenses figures were -$133000.0 in Q1 2026, -$289000.0 in Q4 2025, and $279000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Dyne Therapeutics | 3.94 Bn | 3.94 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -133,000.00 |
| Dec 31, 2025 | -289,000.00 |
| Sep 30, 2025 | 279,000.00 |
| Jun 30, 2025 | -1.60 Mn |
| Mar 31, 2025 | -89,000.00 |
| Dec 31, 2024 | -26,000.00 |
| Sep 30, 2024 | -742,000.00 |
| Jun 30, 2024 | -192,000.00 |
| Mar 31, 2024 | 506,000.00 |
| Dec 31, 2023 | -701,000.00 |
| Sep 30, 2023 | -126,000.00 |
| Jun 30, 2023 | -373,000.00 |
| Mar 31, 2023 | -216,000.00 |
| Dec 31, 2022 | -24,000.00 |
| Sep 30, 2022 | -9,000.00 |
| Jun 30, 2022 | 10,000.00 |
| Mar 31, 2022 | -30,000.00 |
| Dec 31, 2021 | -8,000.00 |